On the public citation graph

Cheap Drugs at What Price to Innovation: Does the Compulsory Licensing of Pharmaceuticals Hurt Innovation

https://doi.org/10.15779/z38zx0x
0 signed · 67 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.1313867openalex-extracted
Compulsory Licensing: Evidence from the Trading with the Enemy Act
inferred← citeshttps://doi.org/10.2139/ssrn.2417532openalex-extracted
Does Compulsory Licensing Discourage Invention? Evidence from German Patents after the US Trading-with-the-Enemy Act
inferred← citeshttps://doi.org/10.2139/ssrn.2725840openalex-extracted
The Problem of the Bargaining Rich: Compulsory Licensing in Developing Markets
inferred← citeshttps://doi.org/10.2139/ssrn.2837849openalex-extracted
Staying Agency Rules: Constitutional Structure and Rule of Law in the Administrative State
inferred← citeshttps://doi.org/10.2139/ssrn.3810207openalex-extracted
Coronavirus, Compulsory Licensing, and Collaboration: Analyzing the 2020 Global Vaccine Response with 20/20 Hindsight
inferred← citeshttps://doi.org/10.2139/ssrn.458620openalex-extracted
Patents, Essential Medicines, and the Innovation Game
inferred← citeshttps://doi.org/10.2139/ssrn.5156493openalex-extracted
Compulsory Licensing of Patented Inventions
inferred← citeshttps://doi.org/10.1002/9781119183839.refsopenalex-snapshot
Refs
inferred← citeshttps://doi.org/10.1002/cncr.30549openalex-snapshot
Improving access to high‐cost cancer drugs in Latin America: Much to be done
inferred← citeshttps://doi.org/10.1007/978-3-030-84193-5_3openalex-snapshot
The Development of Compulsory Licensing in International Patent Laws
inferred← citeshttps://doi.org/10.1007/s40258-017-0306-1openalex-snapshot
Is Compulsory Licensing Bad for Public Health? Some Critical Comments on Drug Accessibility in Developing Countries
inferred← citeshttps://doi.org/10.1016/j.drugpo.2022.103749openalex-snapshot
Permissive regulation: A critical review of the regulatory history of buprenorphine formulations in Canada
inferred← citeshttps://doi.org/10.1016/j.econlet.2017.09.011openalex-snapshot
Compulsory licensing of pharmaceuticals by the developing south
inferred← citeshttps://doi.org/10.1016/j.jdeveco.2017.01.002openalex-snapshot
Compulsory licensing and innovation – Historical evidence from German patents after WWI
inferred← citeshttps://doi.org/10.1016/j.respol.2018.05.008openalex-snapshot
When access to drugs meets catch-up: Insights from the use of CL threats to improve access to ARV drugs in Brazil
inferred← citeshttps://doi.org/10.1016/j.respol.2023.104745openalex-snapshot
Do patent pledges accelerate innovation?
inferred← citeshttps://doi.org/10.1016/s1574-8715(07)00013-9openalex-snapshot
Chapter 13 Patents and Access to Essential Medicines
inferred← citeshttps://doi.org/10.1017/9781009282406.007openalex-snapshot
Boosting Low-Income Countries’ Capacities for Protecting Public Health
inferred← citeshttps://doi.org/10.1017/9781009282406.009openalex-snapshot
Patent Philanthropy
inferred← citeshttps://doi.org/10.1017/9781316471647.002openalex-snapshot
In Praise of an Incentive-Based Theory of Intellectual Property Protection
inferred← citeshttps://doi.org/10.1057/9781137315854_1openalex-snapshot
The New Political Economy of Pharmaceuticals: Conformity and Resistance in the Global South
inferred← citeshttps://doi.org/10.1080/13543776.2019.1643323openalex-snapshot
Drug prices and trends before and after requesting compulsory licenses: the Ecuadorian experience
inferred← citeshttps://doi.org/10.1093/acprof:oso/9780199661619.003.0022openalex-snapshot
Access to medical products, vaccines, and medical technologies
inferred← citeshttps://doi.org/10.1093/oso/9780192857354.001.0001openalex-snapshot
The Patent-Competition Interface in Developing Countries
inferred← citeshttps://doi.org/10.1093/oso/9780192857354.002.0003openalex-snapshot
Copyright Page
inferred← citeshttps://doi.org/10.1093/oso/9780192857354.002.0005openalex-snapshot
Table of Cases
inferred← citeshttps://doi.org/10.1093/oso/9780192857354.002.0006openalex-snapshot
Table of Legislation
inferred← citeshttps://doi.org/10.1093/oso/9780192857354.002.0007openalex-snapshot
Table of Other Legal Instruments
inferred← citeshttps://doi.org/10.1093/oso/9780192857354.002.0008openalex-snapshot
Abbreviations
inferred← citeshttps://doi.org/10.1093/oso/9780192857354.003.0001openalex-snapshot
Introduction
inferred← citeshttps://doi.org/10.1093/oso/9780192857354.003.0002openalex-snapshot
Innovation Incentives in Developing Countries
inferred← citeshttps://doi.org/10.1093/oso/9780192857354.003.0003openalex-snapshot
Technology Transfers in Developing Countries
inferred← citeshttps://doi.org/10.1093/oso/9780192857354.003.0004openalex-snapshot
A Proposed Approach to the Patent–Competition Interface
inferred← citeshttps://doi.org/10.1093/oso/9780192857354.003.0005openalex-snapshot
Unilateral Refusal to License Patents— A Theoretical Perspective
inferred← citeshttps://doi.org/10.1093/oso/9780192857354.003.0006openalex-snapshot
Unilateral Refusal to License Patents— A Proposed Framework
inferred← citeshttps://doi.org/10.1093/oso/9780192857354.003.0007openalex-snapshot
Patent Tying
inferred← citeshttps://doi.org/10.1093/oso/9780192857354.003.0008openalex-snapshot
Excessive Pricing for Pharmaceuticals
inferred← citeshttps://doi.org/10.1093/oso/9780192857354.003.0009openalex-snapshot
Reverse Payment Settlements
inferred← citeshttps://doi.org/10.1093/oso/9780192857354.003.0010openalex-snapshot
Restrictive Licensing Practices
inferred← citeshttps://doi.org/10.1093/oso/9780192857354.003.0011openalex-snapshot
Conclusion
inferred← citeshttps://doi.org/10.1108/qmr-01-2017-0004openalex-snapshot
Returns on social development initiatives of MNEs: issues and perspectives
inferred← citeshttps://doi.org/10.1109/aimsec.2011.6011433openalex-snapshot
Why does the government intervene the market? — An analysis of compulsory trading and compulsory non-trading phenomenon
inferred← citeshttps://doi.org/10.1111/j.1744-1714.2012.01142.xopenalex-snapshot
Inverse Enclosure: Abdicating the Green Technology Landscape
inferred← citeshttps://doi.org/10.1111/j.1748-720x.2009.00366.xopenalex-snapshot
Developing Nations and the Compulsory License: Maximizing Access to Essential Medicines While Minimizing Investment Side Effects
inferred← citeshttps://doi.org/10.1111/j.1748-720x.2009.00367.xopenalex-snapshot
Compulsory Licensing in Canada and Thailand: Comparing Regimes to Ensure Legitimate Use of the WTO Rules
inferred← citeshttps://doi.org/10.1111/j.1758-5899.2012.00178.xopenalex-snapshot
‘Information Aid’ and the Dissemination of Innovation
inferred← citeshttps://doi.org/10.1111/jwip.12223openalex-snapshot
The COVID‐19 pandemic and long‐term incentives for developing vaccines: Patent law under stress
inferred← citeshttps://doi.org/10.11606/issn.2318-8235.v102i0p759-796openalex-snapshot
A licença compulsória de medicamentos como política pública de saúde
inferred← citeshttps://doi.org/10.1177/0098858815622193openalex-snapshot
The Health of eBay
inferred← citeshttps://doi.org/10.1186/1744-8603-7-28openalex-snapshot
Government use licenses in Thailand: an assessment of the health and economic impacts
inferred← citeshttps://doi.org/10.1590/s0102-311x2007000200002openalex-snapshot
A evolução do sistema internacional de propriedade intelectual: proteção patentária para o setor farmacêutico e acesso a medicamentos
inferred← citeshttps://doi.org/10.1590/s0102-311x2007001300010openalex-snapshot
Access to generic antiretrovirals: inequality, intellectual property law, and international trade agreements
inferred← citeshttps://doi.org/10.17323/2072-8166.2021.5.256.285openalex-snapshot
Международно-правовые механизмы регулирования доступа к технологиям здравоохранения
inferred← citeshttps://doi.org/10.17323/2713-2749.2021.3.126.150openalex-snapshot
International Law Regulation on Access to Health Technologies
inferred← citeshttps://doi.org/10.22363/2313-2337-2019-23-1-62-79openalex-snapshot
COMPULSORY LICENSING MECHANISM UNDER INTERNATIONAL AND NATIONAL LAW
inferred← citeshttps://doi.org/10.22409/economica.12i1.p5openalex-snapshot
O papel do instituto da patente no desempenho da indústria farmacêutica
inferred← citeshttps://doi.org/10.25236/ajhss.2023.061608openalex-snapshot
Balancing Pharmaceutical Innovation and the Chinese Public Interest: A Comparative Research of Compulsory Pharmaceutical Licensing Systems
inferred← citeshttps://doi.org/10.26485/spe/2018/106/10openalex-snapshot
Ekonomiczne uzasadnienie dopuszczalności przełamywania monopolu patentowego
inferred← citeshttps://doi.org/10.30915/abd.1141298openalex-snapshot
TİCARETLE BAĞLANTILI FİKRÎ MÜLKİYET HAKLARI ANLAŞMASI ÇERÇEVESİNDE İLAÇ PATENTLERİNDE ZORUNLU LİSANS VE COVID-19 DÖNEMİNDE YAŞANAN BAZI GELİŞMELER
inferred← citeshttps://doi.org/10.3386/w15598openalex-snapshot
Compulsory Licensing - Evidence from the Trading with the Enemy Act
inferred← citeshttps://doi.org/10.3386/w18631openalex-snapshot
Patent Laws and Innovation: Evidence from Economic History
inferred← citeshttps://doi.org/10.4018/978-1-5225-2414-4.ch008openalex-snapshot
Compulsory Licensing of Patents in India
inferred← citeshttps://doi.org/10.4337/9780857935465.00020openalex-snapshot
References
inferred← citeshttps://doi.org/10.4337/9781848440111.00018openalex-snapshot
Bibliography
inferred← citeshttps://doi.org/10.5040/9781472544582openalex-snapshot
Global Health and International Community
inferred← citeshttps://doi.org/10.5433/2178-8189.2011v15n2p31openalex-snapshot
Patentes Farmacêuticas e direito à saúde
inferred← citeshttps://doi.org/10.7551/mitpress/12686.001.0001openalex-snapshot
Innovation Matters: Competition Policy for the High-Technology Economy
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.